185 related articles for article (PubMed ID: 9145890)
1. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.
Ross JI; Eady EA; Cove JH; Jones CE; Ratyal AH; Miller YW; Vyakrnam S; Cunliffe WJ
Antimicrob Agents Chemother; 1997 May; 41(5):1162-5. PubMed ID: 9145890
[TBL] [Abstract][Full Text] [Related]
2. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA.
Ross JI; Eady EA; Cove JH; Ratyal AH; Cunliffe WJ
Dermatology; 1998; 196(1):69-70. PubMed ID: 9557230
[No Abstract] [Full Text] [Related]
3. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
5. Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae.
Karlsson M; Fellström C; Heldtander MU; Johansson KE; Franklin A
FEMS Microbiol Lett; 1999 Mar; 172(2):255-60. PubMed ID: 10188254
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-resistant acne: lessons from Europe.
Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
[TBL] [Abstract][Full Text] [Related]
8. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
[TBL] [Abstract][Full Text] [Related]
9. Resistance of propionibacteria to antibiotics used in the treatment of acne.
Brown JM; Poston SM
J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
[TBL] [Abstract][Full Text] [Related]
10. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.
Lucier TS; Heitzman K; Liu SK; Hu PC
Antimicrob Agents Chemother; 1995 Dec; 39(12):2770-3. PubMed ID: 8593017
[TBL] [Abstract][Full Text] [Related]
11. Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic.
Heller S; Kellenberger L; Shapiro S
Antimicrob Agents Chemother; 2007 Jun; 51(6):1956-61. PubMed ID: 17387155
[TBL] [Abstract][Full Text] [Related]
12. Functional interactions within 23S rRNA involving the peptidyltransferase center.
Douthwaite S
J Bacteriol; 1992 Feb; 174(4):1333-8. PubMed ID: 1531223
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
Eady EA; Cove JH; Holland KT; Cunliffe WJ
Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
[TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE
Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346
[TBL] [Abstract][Full Text] [Related]
15. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes.
Eady EA; Ross JI; Cove JH; Holland KT; Cunliffe WJ
J Antimicrob Chemother; 1989 Apr; 23(4):493-502. PubMed ID: 2501269
[TBL] [Abstract][Full Text] [Related]
16. A putative mechanism underlying secondary metabolite overproduction by Streptomyces strains with a 23S rRNA mutation conferring erythromycin resistance.
Hoshino K; Imai Y; Mukai K; Hamauzu R; Ochi K; Hosaka T
Appl Microbiol Biotechnol; 2020 Mar; 104(5):2193-2203. PubMed ID: 31925486
[TBL] [Abstract][Full Text] [Related]
17. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in
Capitaine A; Woerther PL; Auzou M; Chachaty E; Guérin F; Giard JC; Cattoir V; Isnard C
Microb Drug Resist; 2020 Jul; 26(7):727-731. PubMed ID: 32031922
[No Abstract] [Full Text] [Related]
19. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
Nakase K; Okamoto Y; Aoki S; Noguchi N
J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.
Coates P; Vyakrnam S; Eady EA; Jones CE; Cove JH; Cunliffe WJ
Br J Dermatol; 2002 May; 146(5):840-8. PubMed ID: 12000382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
